Your browser doesn't support javascript.
loading
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
Ainciburu, Marina; Ezponda, Teresa; Berastegui, Nerea; Alfonso-Pierola, Ana; Vilas-Zornoza, Amaia; San Martin-Uriz, Patxi; Alignani, Diego; Lamo-Espinosa, Jose; San-Julian, Mikel; Jiménez-Solas, Tamara; Lopez, Felix; Muntion, Sandra; Sanchez-Guijo, Fermin; Molero, Antonieta; Montoro, Julia; Serrano, Guillermo; Diaz-Mazkiaran, Aintzane; Lasaga, Miren; Gomez-Cabrero, David; Diez-Campelo, Maria; Valcarcel, David; Hernaez, Mikel; Romero, Juan P; Prosper, Felipe.
Afiliação
  • Ainciburu M; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • Ezponda T; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Berastegui N; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • Alfonso-Pierola A; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Vilas-Zornoza A; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • San Martin-Uriz P; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Alignani D; Clinica Universidad de Navarra, Pamplona, Spain.
  • Lamo-Espinosa J; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • San-Julian M; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Jiménez-Solas T; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • Lopez F; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Muntion S; Flow Cytometry Core, Universidad de Navarra, Pamplona, Spain.
  • Sanchez-Guijo F; Clinica Universidad de Navarra, Pamplona, Spain.
  • Molero A; Clinica Universidad de Navarra, Pamplona, Spain.
  • Montoro J; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Serrano G; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Diaz-Mazkiaran A; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Lasaga M; Red de Investigación Cooperativa en Terapia Celular TerCel, ISCIII., Madrid, Spain.
  • Gomez-Cabrero D; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Diez-Campelo M; Red de Investigación Cooperativa en Terapia Celular TerCel, ISCIII., Madrid, Spain.
  • Valcarcel D; Department of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Hernaez M; Department of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Romero JP; Computational Biology Program, Universidad de Navarra, Pamplona, Spain.
  • Prosper F; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Elife ; 122023 01 11.
Article em En | MEDLINE | ID: mdl-36629404
Our blood contains many different types of cells; red blood cells carry oxygen through the body, platelets help to stop bleeding and a variety of white blood cells fight infections. All of these critical components come from a pool of immature cells in bone marrow, which can develop and specialise into any of these. However, as we get older, these immature cells can accumulate damage, including mutations in specific genes. This increases the risk of diseases such as myelodysplastic syndromes (MDS), a type of cancer in which the cells cannot develop and the patient does not have enough healthy mature blood cells. The changes in gene activity in the immature cells have previously been studied using samples from young and elderly people, as well as individuals with MDS. These studies examined large numbers of cells together, revealing differences between young and elderly people, and individuals with MDS. However, this does not describe how the different types alter their behaviour. To address this, Ainciburu, Ezponda et al. used a technique called single-cell RNA sequencing to study the gene activity in individual immature blood cells. This revealed changes associated with maturation that may account for the different combinations of cell populations in younger and older people. The results confirmed findings from previous studies and suggested new genes involved in ageing or MDS. Ainciburu, Ezponda et al. used these results to create an analytical system that highlights gene activity differences in individual MDS patients that are independent of age-related changes. These results provide new insights that could help further research into the development of MDS and the ageing process. In addition, scientists could study other diseases using this approach of analysing individual patients' gene activity. In future, this could help to personalise clinical decisions on diagnosis and treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Envelhecimento Saudável / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Envelhecimento Saudável / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article